SCHEMBL24516932

SCHEMBL24516932

CS(C)(C)C#Cc1c(-c2ccc(Cl)cc2)nc2c(F)cc(F)cn12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 1/20 0.38
▸ AKT2 P31751 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ PTGS2 P35354 2/20 0.34
▸ ALDH1A1 P00352 4/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ TSPO P30536 2/20 0.31
▸ GMNN O75496 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ BLM P54132 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ PSD A5PKW4 2/20 0.31
▸ FAAH O00519 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22615089 0.84 AKT1 (0.39) AKT1AKT2SMN1; SMN2ALDH1A1KDM4E
SCHEMBL24517334 0.83 KDM4E (0.39) AKT1AKT2SMN1; SMN2ALDH1A1KDM4E
SCHEMBL24517328 0.81 ALDH1A1 (0.41) ALDH1A1GAA
SCHEMBL22627381 0.78 AKT1 (0.43) AKT1AKT2SMN1; SMN2ALDH1A1KDM4E
SCHEMBL24517331 0.77 CYP11B1 (0.41) AKT1AKT2SMN1; SMN2PTGS2ALDH1A1
SCHEMBL22614958 0.76 AKT1 (0.43) AKT1AKT2SMN1; SMN2ALDH1A1KDM4E
SCHEMBL24517329 0.75 ALDH1A1 (0.51) ALDH1A1KDM4ETSPOKCNH2GAA
SCHEMBL24517305 0.70 KDM4E (0.53) SMN1; SMN2ALDH1A1KDM4EPOLBGAA
SCHEMBL24517332 0.70 GAA (0.37) SMN1; SMN2PTGS2ALDH1A1KDM4ELMNA
SCHEMBL24517322 0.69 GAA (0.47) PTGS2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220185822-A1 SELECTIVE LIGANDS OF HUMAN CONSTITUTIVE ANDROSTANE RECEPTOR USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) 2022-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185822-A1 SELECTIVE LIGANDS OF HUMAN CONSTITUTIVE ANDROSTANE RECEPTOR NR1I2, NR1H2, NR1H4 AKT1 2762/4885AKT2 2602/4885SMN1; SMN2 4095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback